Company profile
Molecule2Market
Your Vision. Our Expertise. Results Delivered.
- Industry
- Biotechnology Research
- Employees
- 18
- Headquarters
- Melbourne, VIC
- Founded
- 2012
- LinkedIn followers
- 3,577
- Office locations
- 1
Molecule2Market company summary
Molecule2Market is a company in the Biotechnology Research industry, headquartered in Melbourne, VIC, founded in 2012. On LinkedIn the company has around 18 employees and 3,577 followers. Its listed specialties include Short, medium, long term clinical research support, study start up (feasibility, site selection.
What technology does Molecule2Market use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Molecule2Market
Molecule2Market (M2M) is a senior-led boutique CRO based in Australia, delivering agile, expert-driven clinical development services across Australia, New Zealand, and globally through our AICROS alliance. We partner with emerging and mid-sized biotech, medtech and pharma companies to accelerate programs from first-in-human through to multi-country expansion. Our model combines personalized delivery with direct access to experienced clinical leaders who remain hands-on at every stage, ensuring continuity, accountability, and high-quality execution. Operating at the intersection of local insight and global reach, we leverage the advantages of Australia and New Zealand, including efficient regulatory pathways, cost-effective trial delivery, globally accepted data, strong investigator networks, and access to Australian R&D incentives. M2M provides integrated support across the full clinical development lifecycle: clinical operations, regulatory affairs, quality assurance, data management, biostatistics, medical writing, medical monitoring, and pharmacovigilance. Our approach is grounded in operational excellence, quality-by-design, and proactive, risk-based oversight. We have broad therapeutic expertise, with particular strength in early- to mid-phase development, including oncology, CNS, infectious diseases, dermatology, ophthalmology, and medical devices, alongside growing capabilities in novel modalities such as cell and gene therapies. Through our global AICROS network, we enable seamless international study expansion while maintaining consistent oversight and trusted local execution. At M2M, we work as a true extension of our sponsors. Collaborative, responsive, and fully invested in advancing science and delivering results.
Specialties
Where is Molecule2Market located?
Molecule2Market lists 1 location.
Compare companies similar to Molecule2Market
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Molecule2Market molecule2.com | Biotechnology Research | 18 | 2012 | Melbourne, VIC |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Molecule2Market
What does Molecule2Market do?
Molecule2Market (M2M) is a senior-led boutique CRO based in Australia, delivering agile, expert-driven clinical development services across Australia, New Zealand, and globally through our AICROS alliance. We partner with emerging and mid-sized biotech, medtech and pharma companies to accelerate programs from first-in-human through to multi-country expansion. Our model combines personalized delivery with direct access to experienced clinical leaders who remain hands-on at every stage, ensuring continuity, accountability, and high-quality execution. Operating at the intersection of local insight and global reach, we leverage the advantages of Australia and New Zealand, including efficient regulatory pathways, cost-effective trial delivery, globally accepted data, strong investigator networks, and access to Australian R&D incentives. M2M provides integrated support across the full clinical development lifecycle: clinical operations, regulatory affairs, quality assurance, data management, biostatistics, medical writing, medical monitoring, and pharmacovigilance. Our approach is grounded in operational excellence, quality-by-design, and proactive, risk-based oversight. We have broad therapeutic expertise, with particular strength in early- to mid-phase development, including oncology, CNS, infectious diseases, dermatology, ophthalmology, and medical devices, alongside growing capabilities in novel modalities such as cell and gene therapies. Through our global AICROS network, we enable seamless international study expansion while maintaining consistent oversight and trusted local execution. At M2M, we work as a true extension of our sponsors. Collaborative, responsive, and fully invested in advancing science and delivering results.
How many employees does Molecule2Market have?
Molecule2Market has around 18 employees on LinkedIn.
Where is Molecule2Market headquartered?
Molecule2Market is headquartered in Melbourne, VIC.
When was Molecule2Market founded?
Molecule2Market was founded in 2012.
Build a lead list from companies like Molecule2Market
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.